equitybuy

CNC

Trust-weighted public proof page for CNC. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
69 / 100
Current score
1.23
Thesis calls
1
Active decisions
2

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

A short promo post from Until Labs describing in-house interdisciplinary R&D capabilities (CNC machining, molecular biology lab, organ perfusion station, power-electronics dry lab) with a link to learn more. No explicit public-company catalysts, product announcements, contracts, funding, timelines, or measurable claims.

Mentioned: Jul 9, 2026, 1:01 PM EDTConviction: 60 / 100
Source: Until @untillabs 16m At Until Labs, interdisciplinary isn’t just a hype word. Here you’ll find our CNC machine, molec...

Current stance

Recommendationbuy
Authors1
Active decisions2
Latest price$63.41

Top authors on this asset

Investment decisions

CNC
research_buy

CNC
research_buy

Unlock full asset monitoring

Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.